Glibenclamide: a review.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D001645:Biguanides / Q000627:therapeutic use; D001786:Blood Glucose / Q000378:metabolism; D002247:Carbon Isotopes; D002648:Child; D002747:Chlorpropamide / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy; D004285:Dogs; D004347:Drug Interactions; D004357:Drug Synergism; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D005934:Glucagon / Q000378:metabolism; D005947:Glucose / Q000494:pharmacology; D005905:Glyburide / Q000009:adverse effects / Q000627:therapeutic use; D006168:Guinea Pigs; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D066298:In Vitro Techniques; D007328:Insulin / Q000097:blood / Q000627:therapeutic use; D007515:Islets of Langerhans / Q000166:cytology; D008055:Lipids / Q000097:blood; D008112:Liver Glycogen / Q000378:metabolism; D010179:Pancreas / Q000187:drug effects; D011247:Pregnancy; D011485:Protein Binding; D011817:Rabbits; D051381:Rats; D013268:Stimulation, Chemical; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*
D001645:Biguanides; D001786:Blood Glucose; D002247:Carbon Isotopes; D007328:Insulin; D008055:Lipids; D008112:Liver Glycogen; D013453:Sulfonylurea Compounds; D005934:Glucagon; D005947:Glucose; D005905:Glyburide; D002747:Chlorpropamide